1. Home
  2. INDP vs TRUG Comparison

INDP vs TRUG Comparison

Compare INDP & TRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • TRUG
  • Stock Information
  • Founded
  • INDP 2000
  • TRUG 1983
  • Country
  • INDP United States
  • TRUG United States
  • Employees
  • INDP N/A
  • TRUG N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • TRUG
  • Sector
  • INDP Health Care
  • TRUG
  • Exchange
  • INDP Nasdaq
  • TRUG NYSE
  • Market Cap
  • INDP 15.4M
  • TRUG 13.7M
  • IPO Year
  • INDP N/A
  • TRUG N/A
  • Fundamental
  • Price
  • INDP $1.17
  • TRUG $0.93
  • Analyst Decision
  • INDP Strong Buy
  • TRUG
  • Analyst Count
  • INDP 1
  • TRUG 0
  • Target Price
  • INDP $12.00
  • TRUG N/A
  • AVG Volume (30 Days)
  • INDP 21.5K
  • TRUG 10.6K
  • Earning Date
  • INDP 11-04-2024
  • TRUG 10-08-2024
  • Dividend Yield
  • INDP N/A
  • TRUG N/A
  • EPS Growth
  • INDP N/A
  • TRUG N/A
  • EPS
  • INDP N/A
  • TRUG N/A
  • Revenue
  • INDP N/A
  • TRUG $19,112,071.00
  • Revenue This Year
  • INDP N/A
  • TRUG N/A
  • Revenue Next Year
  • INDP N/A
  • TRUG N/A
  • P/E Ratio
  • INDP N/A
  • TRUG N/A
  • Revenue Growth
  • INDP N/A
  • TRUG N/A
  • 52 Week Low
  • INDP $1.03
  • TRUG $0.79
  • 52 Week High
  • INDP $3.25
  • TRUG $11.82
  • Technical
  • Relative Strength Index (RSI)
  • INDP 36.49
  • TRUG 40.30
  • Support Level
  • INDP $1.03
  • TRUG $0.79
  • Resistance Level
  • INDP $1.27
  • TRUG $0.96
  • Average True Range (ATR)
  • INDP 0.14
  • TRUG 0.10
  • MACD
  • INDP -0.01
  • TRUG -0.01
  • Stochastic Oscillator
  • INDP 23.73
  • TRUG 30.55

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About TRUG TRUGOLF HOLDINGS INC

TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.

Share on Social Networks: